In Partnership with Tom White
Artificial intelligence has fast taken over the globe owing to the incredible benefits it provides. It has drastically revolutionized the way machines worked previously, transforming them into tiny robots that are considerably smarter and more intelligent than humans and can perform work better if used properly. It was practically unimaginable to imagine small machines doing tasks that only people could do before, but now the technology is here, and it is up to us to decide how we will utilize it.
The primary objective of AI is to mimic human behavior and thinking by programming computers to carry out human processes such as problem-solving, perception, communication in any language, and even decision-making. Humans have now realized the importance of AI and have begun to integrate it into their daily lives, from politics to economics, and every new development is built on its foundation. Things that were previously difficult to perform have become easier as a result of AI’s capabilities in today’s environment.
AI has performed its job, but it is now up to us humans to figure out how to make it work for us by adding adjustments and making it work for us. Jasjit S. Suri is one person who has been working hard in the field of cardiology and bringing about the long-needed change. He is an American entrepreneur, Chief Technology Officer, businessman, and exceptional scientist who has spent the last 25 years working in the fields of healthcare and artificial intelligence. Because of his extensive expertise, he has worked in a variety of sectors throughout the years, but his primary competencies are in computer sciences, biomedical engineering, software and hardware design, clinical and regulatory engineering, and management. Dr. Suri’s greatest ability is to invent and bring unique ideas to market, sell them, sustain them, and effectively build industries through partnerships. Dr. Suri has over 50 patents, more than 20 trademarks, and has played a key role in the regulatory approval of five items over his career. He has been elected a Fellow of IEEE, AIMBE, AIUM, SVM, and APVS for his exceptional contributions.
AI Is Taking Over Hospitals And Making Them Efficient
AI has taken over hospitals, clinics, and medical institutes, as it has in every other area, to revolutionize the way procedures, treatments, and even operations were previously performed and to enable personnel to care for patients in a more intelligent manner. AI systems have also supplied pharmaceutical firms with a stronger and better base to continue procedures since, as time passes, medications must alter as well, or patients will not be treated appropriately. AI has made it easier to retain a patient record online that is stored forever and can be viewed from anywhere and anywhere.
Dr. Suri has made excellent use of technology, making it easy for insurance companies to incorporate it into improving patient care, such as preventative healthcare. Dr. Suri has processed over 10,000 patients utilizing FDA-certified AtheroEdgeTM from AtheorPointTM, which may run in routine (point of care) and pharmaceutical modes. Dr. Suri’s latest research revealed evidence of improved economics in AI-based therapy design compared to AI-based diagnosis, resulting in larger cost savings in treatment compared to diagnostics. Overall, it’s a win-win situation for everyone.
Prevent Cardiovascular Disease (CVD) Through AtheroEdgeTM Technology
CVD is a terrible illness that claims the lives of around 18 million people each year. A person suffering from Cardiovascular Disease (CVD) has coronary artery obscures, which can lead to a stroke, but you never know when the stroke will occur. Some individuals experience it early, while others do not, and it is entirely dependent on the lifestyle you lead. When CVD is diagnosed, it is critical to immediately adopt a healthy lifestyle, or the consequences will be fatal. Blood cholesterol levels, hypertension, obesity, alcohol consumption, sedentary lifestyle, family stress, coronary artery disease, heart valve disease, diabetes, renal disease, arthritis, erectile dysfunction, neurological diseases, peripheral artery disease, aortic disease, diabetic foot disease, irregular heartbeats (arrhythmias), and other factors all contribute to CVD. The earlier the condition is diagnosed, the easier it is to treat before things go wrong. The form of atherosclerotic plaque changes as a result of the early symptoms. As a result, it is critical to automatically assess the plaque burden in the wall and classify the plaque as symptomatic or asymptomatic.
Dr. Suri has created an image-based system that can automatically quantify the plaque load and compute the composite CVD risk in a few seconds using AtheroEdgeTM technology and describe the plaque using Atheromatic technology. Both technologies are based on the laws of Artificial Intelligence, so you can see how Dr. Suri has utilized them to benefit millions of people worldwide. Dr. Suri has championed the cardiovascular disease/stroke risk assessment system by merging office-based, laboratory-based, image-based, and statin-based biomarkers in a deep learning-based AI framework.
Making Revolutionary Changes Throughout
This is just the tip of the iceberg since Dr. Suri has introduced the usage of AI into additional domains such as endocrinology, neurology, urology, gynecology, immunology, and ophthalmology, to name a few. Even though he was using Covid-19, his cloud-based program COVILAS 2.0 recognized Covid and its kind. Dr. Suri has actually transformed healthcare systems, making it easier for individuals to detect sickness without investing millions of dollars. He has also made some notable advances in Urology, such as 3-D biopsy for men’s prostates and the development of the UroScan, ThyroScan, and GyneScan product lines. The healthcare business will grow as a result of this, and individuals will be able to receive treatment without having to worry about the cost.
Dr. Jasjit has authored 350 articles about his work and the improvements and innovations it is certain to bring. He’s even improving The AtheroEdgeTM 3.0, and the system is in the works, with cutting-edge improvements in Deep Learning and Hybrid Deep Learning. Visit his website http://www.atheropoint.com/ to learn about it in detail and become a part of the innovation.
Advertising disclosure: We may receive compensation for some of the links in our stories. Thank you for supporting LA Weekly and our advertisers.